Teacher Retirement System of Texas bought a new stake in Envista Holdings Co. (NYSE:NVST – Free Report) in the 4th quarter, Holdings Channel.com reports. The fund bought 58,969 shares of the company’s stock, valued at approximately $1,138,000.
Several other large investors have also recently added to or reduced their stakes in the business. Thurston Springer Miller Herd & Titak Inc. acquired a new position in shares of Envista during the 4th quarter valued at about $53,000. Lecap Asset Management Ltd. acquired a new position in Envista during the fourth quarter worth approximately $281,000. Hotchkis & Wiley Capital Management LLC purchased a new position in Envista during the third quarter worth approximately $14,965,000. Geode Capital Management LLC boosted its holdings in shares of Envista by 2.5% in the 3rd quarter. Geode Capital Management LLC now owns 2,895,653 shares of the company’s stock valued at $57,233,000 after purchasing an additional 71,435 shares during the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of Envista during the 3rd quarter valued at $521,000.
Envista Price Performance
Shares of NYSE NVST opened at $16.96 on Friday. The business has a 50 day moving average price of $19.59 and a two-hundred day moving average price of $19.60. Envista Holdings Co. has a fifty-two week low of $15.15 and a fifty-two week high of $23.00. The firm has a market cap of $2.92 billion, a PE ratio of -2.61, a price-to-earnings-growth ratio of 1.27 and a beta of 1.33. The company has a quick ratio of 1.76, a current ratio of 2.04 and a debt-to-equity ratio of 0.44.
Analyst Upgrades and Downgrades
A number of research analysts recently weighed in on NVST shares. Wells Fargo & Company set a $19.00 target price on Envista in a report on Saturday, March 8th. Jefferies Financial Group lifted their price objective on Envista from $20.00 to $22.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. UBS Group dropped their target price on shares of Envista from $23.00 to $21.00 and set a “neutral” rating for the company in a research report on Monday, March 10th. New Street Research set a $19.00 price target on shares of Envista in a research report on Thursday, March 6th. Finally, JPMorgan Chase & Co. dropped their price objective on shares of Envista from $20.00 to $19.00 and set a “neutral” rating for the company in a research report on Thursday, March 6th. Two analysts have rated the stock with a sell rating, ten have given a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $20.18.
View Our Latest Stock Analysis on Envista
About Envista
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Featured Articles
- Five stocks we like better than Envista
- Airline Stocks – Top Airline Stocks to Buy Now
- MarketBeat Week in Review – 03/24 – 03/28
- The 3 Best Retail Stocks to Shop for in August
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Using the MarketBeat Dividend Tax Calculator
- 4 Healthcare Stocks With Massive Gains—and More to Come
Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Co. (NYSE:NVST – Free Report).
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.